RxDoctor Payments Data

Christopher Tolan, MD

Facial Plastic Surgery · Woodbury, MNNPI 1043256357

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $55,009 of the $55,981 with a category attached, or 98.3%. AbbVie accounts for 98.5% of it on its own, with 3 other manufacturers making up the rest.

$55,981in general payments, 2019–2025

Across 115 payments — averaging $486.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$55K
  • Organogenesis Inc.$652
  • NEW World Medical,inc.$94
  • Integra Lifesciences Corporation$94

What the payments were for

  • Speaking & faculty fees$55,00998%
  • Food & beverage$9472%
  • Education$250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)66$55,140
Organogenesis Inc.41$652
NEW World Medical,inc.5$94
Integra Lifesciences Corporation3$94

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few facial plastic surgery providers in Minnesotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$258,148
Medicare patients
104
Services billed
1,207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin83$692
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha37$445
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen58$322
Methylprednisolone41$257
ValacyclovirValacyclovir Hcl25$232
Tranexamic Acid27$182
Ondansetron OdtOndansetron13$47

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Woodbury

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →